ROARABLE
FREE $100K
Today Screener Big Ideas Track Record 💰 $100K Arena 🎲 Predictions 🏛️ Insiders 8 Analysts
Stock Ratings / Consumer Discretionary / AHG
RSKD (54) QNST (70) MAX (69) NUTX (84) ⌘ Pro Terminal →

Akso Health Group ADS (AHG) — RQD Stock Rating Cockpit

$1.31 +4.17% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $1.32

Akso Health Group ADS (AHG) carries a Roarable Rating of E (Strong Sell) with 32/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE E • RED ALERT Cap $1.08B
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on AHG Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is AHG stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, Akso Health Group ADS (NASDAQ: AHG) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 32/100 at a spot price of $1.31 (+4.17% 1D, market cap $1.08B). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 8/20, SEC Balance-Sheet Forensics 8/20, FRED Macro Regime Fit 5/20, and Executive Insider Alignment 3/20. Across 1009 tracked Consumer Discretionary issuers, AHG ranks #843 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does AHG compare to RSKD and QNST in the Consumer Discretionary sector?
▼

Within the Consumer Discretionary sector (Business Services), AHG carries a Roarable E (32/100 RQD), trailing P/E of N/A, gross margin of -0.1%, and ROIC of —. By comparison, RSKD (Riskified Ltd. (Class A)) holds a D+ grade (54/100 RQD, P/E N/A, ROIC -20.3%, cap $1.17B) and QNST (QuinStreet Inc.) posts a B- grade (70/100 RQD, P/E N/A, ROIC 2.6%, cap $995.7M). Among the 5-stock peer group, NUTX leads on earnings multiple (20.3x) while NUTX leads on capital efficiency (85.0% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for AHG?
▼

Per AHG's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-03-31, CIK 0001702318), Akso Health Group ADS generated $13.8M in revenue (-6.4% YoY), -$18.7M in net income, and -$12.8M in free cash flow against $212.0M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $1.32 (+0.56%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 8/20 (D-) • 0% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record Warning: Scores below 50 (32/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-9.2% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERRED ALERT • E
025507510032
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk E
Cash (8)Whales (8)SEC (8)Macro (5)CEO (3)
Each axis scored 0–20
12M PRICE TARGET CONE-11.5% Base Target
$3 Bull$1 Base$1 Bear
📬 FREE AHG RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for AHG)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (32/100 Composite)
🔍 WHY AHG SCORES 32/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Cash Engine Quality+8/20 pts (25% of score)

SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 0% Gross Margin

▲ #2 Bullish Driver: Whale & Options Positioning+8/20 pts (25% of score)

20D Institutional Volume Accumulation (±12.5% realized swing band)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
40
Grade D$1.36-9.6% Next Q
Q2 (-2Q)
37
Grade E$1.23+14.6% Next Q
Q3 (-1Q)
35
Grade E$1.41-7.1% Next Q
Current
32
Grade E$1.31-9.2% Hist 90D α
Trajectory: D (40) → E (32)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a AHG Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While AHG currently carries a cautious 32/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Consumer Discretionary with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($1.03) and Max Pain ($1.38) forces dealer call-delta covering toward $2.63.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $AHG• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “AHG Beats Next Quarter EPS Consensus (Dec 29, 2026) & Holds Above 200D SMA”
YES 32%NO 68%Trade / Inspect Odds →
RSI-14 MOMENTUMNEUTRAL RANGE
52.930 Oversold · 70 Hot
ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)
3.80>3.0 Fortress Safe
PIOTROSKI F-SCOREWEAK QUALITY (1–4)
2 / 99-Pt Accounting
52-WEEK LASER RANGE35% OF RANGE
L: $1$1.31H: $3
1. Money & Cash Health● WEAK
Are profits real cash in the bank?

Weak cash conversion or heavy valuation strain compared to actual cash earned.

Factor Grade: D-RQD 8 / 20
2. Big Money & Insiders● TRIMMING
Are whales & executives buying or selling?

Insiders and big institutional desks have been trimming shares rather than stepping up to buy.

Factor Grade: ERQD 11 / 40
3. Hidden Risks & Market Weather● WARNING
SEC fine-print scan & interest-rate fit

High sensitivity to tight interest rates or new risk warnings added to recent SEC annual filings.

Factor Grade: ERQD 13 / 40
MULTI-MODEL JEV QUANT JURY DELIBERATION

3-of-3 JEV AI Jury Bearish Warning on AHG

Cash & Moat Bull AI
ROIC & Free Cash Flow Model
BEARISH (40)

14.0% ROIC with -0.1% gross margin and -1.12% FCF yield.

SEC Forensic Auditor AI
10-K Accruals & Altman-Z Guard
BEARISH (40)

Altman-Z 4.20 and Piotroski 2/9 pass balance-sheet audit.

Whale & Macro Hawk AI
Options Skew, 13F & Fed NetLiq
BEARISH (27)

11/40 institutional & smart-money positioning score with 5/20 macro alignment.

Bull Case: Why Buyers Like AHG
  • ✓Established market leader in Consumer Discretionary with deep daily trading liquidity.
Bear Case: What Could Go Wrong
  • !Company executives have done more routine share selling than personal cash buying lately.
  • !Sensitive to high interest rates and tighter Federal Reserve market liquidity.
  • !Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring AHG)

  • ✓Walkthrough of AHG's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) →$100K Arena
AHG // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -38.79%▼ DESCENDING CHANNEL
2026-11-03O $1.33H $1.33L $1.26C $1.31VOL 4.9K
RES: $1.49SUP: $0.49SMA50: $1.03SMA200: $1.51
$2.31$1.87$1.42$0.98$0.54RES $1.49SUP $0.49$1.312026-05-042026-06-172026-08-042026-09-182026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

AHG Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 AHG Butterfly Map → + Track AHG →
Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
8.0%/yr Implied 5Y Growth

vs. -6.4% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on AHG today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for AHG. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for AHG today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (AHG)

Consumer Discretionary Rank #843 of 1009 ⚔️ RSKD vs AHG Full Matrix →

1. Head-to-Head Consumer Discretionary Peer Comparison (AHG vs. RSKD, QNST, MAX, NUTX)

Industry: Business Services (88 Tracked Issuers)

Across 1009 tracked Consumer Discretionary securities in the Roarable RQD universe, Akso Health Group ADS (AHG) ranks #843 by composite RQD confidence (32/100, grade E) and #498 by equity capitalization ($1.08B). Within this direct 5-issuer industry benchmark cohort, NUTX leads on earnings valuation at 20.3x trailing P/E, while NUTX leads on capital efficiency and profitability with 85.0% ROIC and 50.8% gross margin. NUTX currently holds the highest overall quantitative score in the immediate peer group at 84/100 (A-) compared with AHG at 32/100 (E).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
AHG ACTIVE
Akso Health Group ADS
E 32/100 — -0.1% — +4.17% $1.08B Benchmark Subject
RSKD
Riskified Ltd. (Class A)
D+ 54/100 — 51.7% -20.3% -1.05% $1.17B /rskd-vs-ahg →
QNST
QuinStreet Inc.
B- 70/100 — 10.1% 2.6% +0.92% $995.7M /qnst-vs-ahg →
MAX
MediaAlpha Inc. (Class A)
C+ 69/100 32.6x 15.0% 19.7% +0.20% $873.1M /max-vs-ahg →
NUTX
Nutex Health Inc.
A- 84/100 20.3x 50.8% 85.0% -7.27% $1.37B /nutx-vs-ahg →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2026-03-31 • CIK 0001702318 ↗

In its most recent audited fiscal period (FY2025, filed 2026-03-31), Akso Health Group ADS (AHG) reported GAAP revenue of $13.8M (-6.4% vs. FY2024 revenue of $14.8M , and +472.9% cumulative change since FY2023) , GAAP net income of -$18.7M, operating cash flow of -$12.8M, and free cash flow of -$12.8M (-1350.9% YoY). On the balance sheet, AHG closed FY2025 with $212.0M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 2/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2026-03-31 $13.8M -$18.7M -$12.8M -$12.8M $212.0M —
FY2024 (FY) 2025-03-31 $14.8M -$135.0M $1.2M $1.0M — —
FY2023 (FY) 2024-03-31 $2.4M -$9.5M $1.4M $1.4M — —

3. AHG Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is AHG stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Akso Health Group ADS (NASDAQ: AHG) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 32/100 at a spot price of $1.31 (+4.17% 1D, market cap $1.08B). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 8/20, SEC Balance-Sheet Forensics 8/20, FRED Macro Regime Fit 5/20, and Executive Insider Alignment 3/20. Across 1009 tracked Consumer Discretionary issuers, AHG ranks #843 in composite RQD confidence.

How does AHG compare to RSKD and QNST in the Consumer Discretionary sector?

Within the Consumer Discretionary sector (Business Services), AHG carries a Roarable E (32/100 RQD), trailing P/E of N/A, gross margin of -0.1%, and ROIC of —. By comparison, RSKD (Riskified Ltd. (Class A)) holds a D+ grade (54/100 RQD, P/E N/A, ROIC -20.3%, cap $1.17B) and QNST (QuinStreet Inc.) posts a B- grade (70/100 RQD, P/E N/A, ROIC 2.6%, cap $995.7M). Among the 5-stock peer group, NUTX leads on earnings multiple (20.3x) while NUTX leads on capital efficiency (85.0% ROIC).

What are the biggest fundamental strengths and SEC risk factors for AHG?

Per AHG's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-03-31, CIK 0001702318), Akso Health Group ADS generated $13.8M in revenue (-6.4% YoY), -$18.7M in net income, and -$12.8M in free cash flow against $212.0M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

Where is AHG trading relative to its 50-day, 200-day, and 52-week technical levels?

AHG last traded at $1.31 (+4.17% on volume of 2,951 shares), positioning the stock +27.18% above its 50-day simple moving average ($1.03) and -13.25% below its 200-day simple moving average ($1.51). Across its 52-week range of $0.68 to $2.50, AHG sits at the 34.6% percentile with a 14-day RSI of 52.9 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.15 to $1.47).

Direct Sub-Reports: AHG RQD Cockpit AHG 12M Forecast AHG Earnings & Move AHG Dividends & DRIP AHG Insiders & 13F AHG Whale Options AHG Profit Sankey AHG News & Why
ROARABLE RATING BRIEF • RQD 32/100 (E) ✓ SEC XBRL & RQD VERIFIED

AHG — Akso Health Group ADS: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2026-03-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

Akso Health Group ADS (AHG) earns a live Roarable RQD composite score of 32/100, corresponding to a E letter grade (Roarable Strong Sell) at a spot price of $1.31 (+4.17% 1D, market capitalization $1.08B).

  • Fundamental Cash Engine (8/20): Anchored by return on invested capital (ROIC) of —, gross margin of -0.1%, operating margin of -60.0%, and free cash flow yield of -1.12%.
  • Whale 13F & Options Flow (8/20) + Insider Conviction (3/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (5/20) + Forensic Balance Sheet (8/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 2/9, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

Akso Health Group ADS is a NASDAQ-listed issuer classified in the Consumer Discretionary sector and Business Services industry,. — for specific product lines, customer segments, or revenue model details. The profile identifies the company only at the sector, industry, and exchange level.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2026-03-31), Akso Health Group ADS (AHG) reported $13.8M in annual revenue (up from $14.8M in FY2024, -6.4% YoY) and -$18.7M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($2.4M revenue, -$9.5M net income) through FY2025, AHG scaled operating cash flow to -$12.8M and free cash flow to -$12.8M, backed by $212.0M in total assets against $0 in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (E • RQD 32/100): Established market leader in Consumer Discretionary with deep daily trading liquidity. Free cash flow yield of -1.12% and institutional whale pillar of 8/20. With Fundamental Cash Engine at 8/20 and Institutional Whale Flow at 8/20, sustained execution supports upside toward the upper end of the $0.68 – $2.50 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against -60.0% operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Operating in Business Services (Consumer Discretionary), AHG carries a macro regime beta of 1.00 and gross margin of -0.1%.

  • Key Question #1: Can AHG sustain or expand its -60.0% operating margin and — ROIC against Business Services peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $13.8M and free cash flow of -$12.8M, how will capital allocation balance growth reinvestment against $0 in total debt?
  • Key Question #3: How sensitive is AHG's equity valuation to Consumer Discretionary capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

AHG Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Akso Health Group ADS (AHG) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to AHG Debate Forum (3) ↓
🟡 MARKET WIRE TradingView • 10d ago
Akso Health Group Estimates – NASDAQ:AHG

<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTE9LTXc1MURydmdGcFBPc0xqZ3N2MFJLaXd0Zy1IS1VfdU4tMXV2RU50aDJwS3AwQkhLUTF6ZUdoUXFvbDhOQ0oxYVRyc3BrYXFyWnE3YjZkVU0zbG1EVXdrX2NudDdVN2VwYmQ0YkNOcmpNem04cnFB?oc=5"

Read Full Source ↗
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

AHG Bull vs. Bear Conversation Board — What's Your Call at $1.31?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON AHG 🐻 33% BEARISH CONVICTION
1. Pick Your Side on AHG:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
SI SiliconVal_Bull RQD DEBATE OPENER • Growth & Tech Investor 🐂 BULLISH 🎯 Target: $1.45 (+15.1%)
📌 Pinned Debate

The share price of 1.33 sits near the low end of its $0.68 - $2.5 52-week range while the company reports 2.5 Altman Z-Score.

The share price of 1.33 sits near the low end of its $0.68 - $2.5 52-week range while the company reports 2.5 Altman Z-Score.. When you look under the hood at AHG, Fundamental Cash Engine is 8/20 with -0.1% gross margins and 0.0% ROIC. Bears are staring in the rearview mirror while institutional 13F flow (8/20) has been quietly accumulating below $2.50. My 12M target is $1.45.

VolSurface_Trader 🐂 BULL

@CreditSpread_Watch Shorting a 8/20 institutional whale-flow stock at $1.26 is dangerous when funds are rotating into Consumer Discretionary.

CR CreditSpread_Watch RQD DEBATE OPENER • Balance Sheet Analyst 🐻 BEARISH 🎯 Target: $1.01 (-19.8%)
Spot @ $1.26

Negative operating margin of -60% and ROIC of 0% alongside a Piotroski F-Score of 2 out of 9 signal weak cash generation and elevated f

Negative operating margin of -60% and ROIC of 0% alongside a Piotroski F-Score of 2 out of 9 signal weak cash generation and elevated forensic risk.. Look at the math on AHG: paying current EV/EBITDA multiples for 0.0% ROIC and -60.0% operating margins leaves zero margin of safety if Business Services demand softens. I'd wait for a retest of $1.11 before getting long.

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $202.06 -1.26% AAPL $338.32 -1.83% MSFT $507.12 -2.83% TSLA $403.82 +1.00% PLTR $178.34 -3.13% SOFI $16.60 -0.95% IBIT $43.35 -5.42% GLD $361.65 -3.59%